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Abstract
Mitochondrial dysfunction and endoplasmic reticulum (ER) stress have been implicated in hepatic steatosis and insulin
resistance. The present study investigated their roles in the development of hepatic steatosis and insulin resistance during
de novo lipogenesis (DNL) compared to extrahepatic lipid oversupply. Male C57BL/6J mice were fed either a high fructose
(HFru) or high fat (HFat) diet to induce DNL or lipid oversupply in/to the liver. Both HFru and HFat feeding increased hepatic
triglyceride within 3 days (by 3.5 and 2.4 fold) and the steatosis remained persistent from 1 week onwards (p,0.01 vs Con).
Glucose intolerance (iAUC increased by ,60%) and blunted insulin-stimulated hepatic Akt and GSK3b phosphorylation
(,40–60%) were found in both feeding conditions (p,0.01 vs Con, assessed after 1 week). No impairment of mitochondrial
function was found (oxidation capacity, expression of PGC1a, CPT1, respiratory complexes, enzymatic activity of citrate
synthase & b-HAD). As expected, DNL was increased (,60%) in HFru-fed mice and decreased (32%) in HFat-fed mice (all
p,0.05). Interestingly, associated with the upregulated lipogenic enzymes (ACC, FAS and SCD1), two (PERK/eIF2a and IRE1/
XBP1) of three ER stress pathways were significantly activated in HFru-fed mice. However, no significant ER stress was
observed in HFat-fed mice during the development of hepatic steatosis. Our findings indicate that HFru and HFat diets can
result in hepatic steatosis and insulin resistance without obvious mitochondrial defects via different lipid metabolic
pathways. The fact that ER stress is apparent only with HFru feeding suggests that ER stress is involved in DNL per se rather
than resulting from hepatic steatosis or insulin resistance.
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Introduction
Non-alcoholic fatty liver disease (NAFLD) affects approximately
10–20% of the population and is a hepatic manifestation of the
metabolic syndrome which includes insulin resistance, obesity and
type 2 diabetes [1,2]. NAFLD defines a spectrum of liver
abnormalities from benign simple non-alcoholic fatty liver (NAFL
or steatosis) to steatohepatitis (NASH) which is associated with
inflammation and liver damage [2]. Although the causal
relationship between hepatic steatosis and insulin resistance is a
matter of debate, NAFL is believed to be a prerequisite for NASH
[3].
The effect of dietary fructose and fat on the development of
NAFL and insulin resistance has attracted much attention due to
their overconsumption in the modern society [4,5]. A number of
studies including our own have revealed the critical role of active
lipid metabolites such as long chain fatty acyl-CoAs, diacylglycerol
and ceramide in generating insulin resistance in muscle and liver
[6,7]. As well as being an important site of fatty acid oxidation, the
liver is also a major organ for de novo lipogenesis and its insulin
sensitivity appears to be more vulnerable to the insult of lipid
accumulation compared to muscle [8].
It has been suggested that defects in mitochondrial substrate
oxidation would cause lipid accumulation [9] and thus insulin
resistance. In the liver, partial deletion of a key mitochondrial
protein for b-oxidation causes hepatic steatosis and insulin
resistance [10]. Furthermore, mitochondrial dysfunction has been
demonstrated to occur prior to the appearance of hepatic steatosis
and insulin resistance [11]. While these findings highlight the
potential role of mitochondrial dysfunction in NAFL, it is not
known whether this is a primary cause of hepatic steatosis and
insulin resistance or arises as a secondary defect [12].
Recently, endoplasmic reticulum (ER) stress has been proposed
as a key intersection of lipogenesis, inflammation and insulin
resistance in the liver [13,14]. ER stress has been reported to
promote a JNK-dependent serine phosphorylation of IRS-1 and
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key ER stress signalling molecules has also been shown to enhance
lipogenesis, contributing to hepatic steatosis and insulin resistance
[17]. However, it is not known whether ER stress is also associated
with an increase in DNL or lipid influx, as the majority of the
existing data was derived from genetically obese or prolonged
chronic high fat feeding models [13,15,16,18].
As high-fat (HFat) and high-fructose (HFru) diets are known to
cause hepatic steatosis by increased extrahepatic lipid supply and
hepatic DNL, respectively [19,20], the present study aimed to
examine the role of mitochondrial dysfunction and ER stress in the
development of hepatic steatosis and insulin resistance induced by
these two distinct lipid metabolic pathways. Our findings show
that the development of hepatic steatosis and insulin resistance
resulting from excessive DNL is closely associated with ER stress
but not mitochondrial dysfunction. In contrast, lipid oversupply
induced steatosis and insulin resistance occurred along with JNK
activation but without ER stress. The present study suggests a
divergence in ER stress pathways between intrahepatic DNL and
extrahepatic lipid supply on the initiation of hepatic steatosis and
insulin resistance.
Materials and Methods
Animals
Male C57BL/6J mice (14 weeks) from the Animal Resources
Centre (Perth, Australia) were kept at 2261uC on a 12-h light/
dark cycle. After 1 week of acclimatization, mice were fed ad libitum
for up to 8 weeks with either a chow (CH), HFru, or HFat diet.
CH diet consisted of 70% calories from starch, ,10% calories
from fat, and ,20% calories from protein (Gordon’s Specialty
Stock Feeds, Yanderra, Australia), HFru diet (35% fructose, 35%
starch, ,10% fat and ,20% protein), a HFat diet (60% from
saturated fat, 20% protein, and ,20% carbohydrate). The
detailed recipes for HFru and HFat diets are described in our
previous studies [19,21]. All experiments were approved by the
Animal Ethics Committees of the Garvan Institute (#0847) and
RMIT University (#1012).
Body weight and food intake were measured twice weekly. The
whole body metabolic rate was assessed at 22uC using an indirect
calorimeter (Oxymax, Columbus Instruments, OH, USA) as
described previously [22], between 4–7 days after the commence-
ment of the HFru or HFat feeding. Following 5–7 hours of fasting,
mice were culled and tissues of interest were collected and freeze-
clamped immediately. Epididymal fat mass was weighed using an
analytical balance. Liver triglycerides were extracted by the
method of Folch [6,23] and determined by a Peridochrom
Triglyceride GPO-PAP kit (Roche Diagnostics, Australia). In
separate experiments, glucose tolerance tests (GTT; 3 g glucose/
kg BW, i.p.) were performed using a glucometer (AccuCheck II;
Roche, New South Wales, Castle Hill, Australia). For the
assessment of insulin signaling in the liver, the mice were injected
with insulin (2 U/kg BW, i.p.) along with glucose (3 g/kg BW) to
avoid hypoglycemia 40 min before tissues were collected. DNL
was determined by measuring the incorporation of [
3H]-H2O into
triglyceride in the liver as described previously [24]. Briefly, mice
were injected with [
3H]-H2O (20 mCi/g BW, i.p.). Blood sample
and liver samples were collected at 90 min for the measurement of
radioactivity in plasma and liver triglyceride using a b-scintillation
counter.
Mitochondrion-dependent oxidation of substrates
Palmitate and glutamate oxidations were measured in liver
homogenates using methods described previously [12] with
modifications. Briefly, approximately 30 mg of fresh liver was
homogenized in an ice-cold Tris buffer containing (in mM) 250
sucrose, 10 Tris-HCl and 1 EDTA, pH 7.4. The liver homogenate
(50 ml) was incubated with a 450 ml reaction mixture (pH 7.4).
Final concentrations of the reaction mixture were (in mM): 100
sucrose, 80 KCl, 10 Tris-HCl, 5 KH2PO4, 1 MgCl2, 2 malate, 2
ATP, 1 dithiothreitol, 0.2 EDTA, and 0.3% fatty acid–free BSA.
Substrates (in mM) were 0.2 [1-
14C]-palmitate (0.5 mCi) plus 2 L-
carnitine and 0.05 coenzyme A or 10 [1-
14C]-glutamate (0.1 mCi).
After 90 min of incubation at 30uC, the reaction was stopped by
0.1 ml of ice-cold 1 M perchloric acid. CO2 produced during the
incubation was captured in 0.1 ml of 1 M NaOH. For palmitate
oxidation,
14C counts present in the acid-soluble fraction were also
measured and combined with the CO2 values to give the total
palmitate oxidation rate.
Citrate synthase and b3 – hydroxyacyl– CoA
dehydrogenase (b-HAD) activity
Approximately 20 mg of frozen liver tissue was homogenized in
175 mM KCl and 1.98 mM EDTA containing buffer (pH 7.4)
with a glass homogenizer before subjected to three freeze-thaw
cycles. Citrate synthase and b-HAD activities were determined as
described previously [25,26], using a Flexstation 3 plate reader
(Molecular Devices, Sunnyvale, CA). Enzyme activities are
presented as units per gram wet weight, where units are defined
as micromoles per minute.
NADPH oxidase activity and glutathione (GSH) content
NADPH oxidase-driven superoxide production in the frozen
liver tissue was determined using lucigenin-enhanced chemilumi-
nescence. Approximately 10 mg of tissue was pre-incubated in
Krebs–HEPES buffer containing diethylthiocarbamic acid (1 mM)
at 37uC for 45 min to inactivate superoxide dismutase. NADPH
(100 mM), a substrate for NADPH oxidase was supplemented
either alone or in the presence of diphenylene iodonium (5 mM),
which is a flavoprotein inhibitor that inhibits NADPH oxidase.
Follow by 300 uL of Krebs-HEPES buffer containing lucigenin
(5 mM) and the appropriate sample were placed into a 96-well
Optiplate, and superoxide production was measured and quan-
tified as previously described [27]. Intracellular GSH content was
assessed in de-proteinated whole-liver lysate using the glutathione
assay kit (Cayman Chemical Co., Ann Arbor, MI) according to
manufacturer’s instruction. Briefly, 10 mg of frozen tissue was
homogenized in the MES buffer provided. The homogenates were
then de-proteination using metaphosphoric acid and triethanol-
amine, the supernatant was then collected for the analysis of
intracellular GSH content. Data is expressed as micro molar of
GSH per mg of wet tissue weight.
Western blotting
Liver samples were homogenized in ice-cold lysis buffer at
pH 7.5 containing (in mM): 50 Tris, 150 NaCl, 1% Triton X-100,
10 NaP, 100 NaF, 2 Na3VO4, 1 EDTA, 1 EGTA and 10%
glycerol supplemented with protease inhibitor cocktail tablets
(Roche Diagnostics Pty Ltd, Australia) and DL-dithiothreitol.
Protein samples were then denatured in SDS sample buffer
(125 mM Tris-HCl, pH 6.8, 50% glycerol, 2% SDS, 5% b-
mercaptoethanol and 0.01% bromophenol blue). The insulin
signal transduction was assessed by total- and phospho (Ser473)-
Akt, total- and phospho (Ser219)- glycogen synthase kinase 3b
(GSK-3b, Cell Signaling, USA). Key lipogenic enzymes were by
Western blotting using specific antibodies including acetyl-CoA
carboxylase (ACC, Upstate, USA), fatty acid synthase (FAS,
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USA). Mitochondrial metabolic capacity: proliferator–activated
receptor co-activator 1a (PGC-1a, Chemicon International,
Temecula, USA), voltage dependent anion channel (VDAC, Cell
signaling, USA), carnitine palmitoyltransferase-1 (CPT-1, Santa
Cruz, USA), cytochrome oxidase subunit 1(COX-1, Abcam, USA)
and an antibody cocktail that recognizes several subunits of the
mitochondrial respiratory chain (MS601; Mitosciences, Eugene,
USA). ER stress: total- and phospho (Thr980)- pancreatic ER
kinase (p-PERK, Cell signaling, USA), total- and phospho
(Ser724)- inositol-requiring kinase 1 (IRE1, Abcam, USA), ATF-
6 a, total- and phospho (Ser51)- eukaryotic translation initiation
factor 2a (eIF2a, Santa Cruz, USA). Stress-activated kinases: total-
and phospho (Thr183/Tyr185)-c-Jun N-terminal kinase (JNK),
total- and phospho (Ser176/180)- IkB kinase a/b (total-IKK a/b)
and IkBa (Cell Signaling, USA). Immunolabeled bands were
quantified by densitometry and representative blots are shown.
Analysis of gene expression
Total RNA was extracted from liver tissue using TRIZOLH
(Invitrogen, USA) according to manufacturer’s instructions.
Reverse transcription was carried out using 0.2 mg of RNA using
the High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, USA). Real time PCR was carried out using the IQ
SYBR Green Supermix (2X) (Biorad Laboratories Inc, USA) for
murine sterol regulatory element-binding protein-1c (SREBP-1c)
and carbohydrate responsive element binding protein (ChREBP).
Primer sequences are described in Table S1. The gene expression
from each sample was analysed in duplicates and normalized
against the housekeeper 18S. All reactions were performed on the
iQ
TM5 Real Time PCR Detection System (Biorad Laboratories
Inc, USA). The results are expressed as relative gene expression
using the DCt method.
XBP1 mRNA cleavage by IRE1
Total RNA extracted was PCR using the specific primer set for
mouse X-box binding protein (XBP1; Table S1) which amplifies a
601-bp cDNA product encompassing the IRE1 cleavage sites. This
fragment was further digested by PstI to reveal a restriction site that
is lost afterIRE1-mediated cleavage and splicingofthemRNA.The
cDNA fragments were resolved on 2% agarose gels and analysed by
FluorChemH Imaging System (Alpha Innotech, USA).
Statistical analyses
Data are presented as means 6 SE. One-way analysis of
variance was used for comparison of relevant groups. When
significant differences were found, the Tukey-Kramer multiple
comparisons test was applied. Differences at p,0.05 were
considered to be statistically significant.
Results
Both HFru and HFat feeding led to hepatic steatosis
Both HFru and HFat feeding tended to cause slightly more
weight gain starting at week 1 (Figure 1A) and significantly
increased adiposity (60% increase in epididymal fat mass, p,0.05),
which occurred as early as 3 days (Figure 1B). The caloric intake
was greater in both HFru (by 25% vs CH, p,0.01) and HFat
group (by 30% vs CH, p,0.01) in the first week which was
gradually stabilized to be ,10–12% in both groups over 8 weeks
of feeding (Table 1). The basal metabolic rate was enhanced in
mice fed a HFru or HFat diet (10% and 12% increase in VO2,
respectively, p,0.01) compared to CH-fed mice (Table 1). Basal
plasma glucose was slightly elevated after 8 weeks of HFru or HFat
feeding while plasma levels of insulin and triglyceride were
unchanged (Table 1).
As expected, the hepatic triglyceride content was readily
augmented (after 3 days) in response to HFru or HFat feeding
(p,0.01; Figure 1C) indicating the development of steatosis.
Interestingly, HFru feeding resulted in a more pronounced
triglyceride accumulation than that of HFat feeding during the 8
weeks of the study. As elevated liver triglyceride content was found
to remain similarly elevated (HFru 2.8 fold, HFat 1.5 fold, p,0.01)
from week 1 onwards (Figure 1C), our subsequent studies focused
on the one week model to investigate the mechanism involved in
the development of hepatic steatosis and insulin resistance.
Both HFru and HFat feeding resulted in glucose
intolerance and impairment in hepatic insulin signal
transduction
HFru and HFat-fed mice displayed impaired glucose tolerance,
as reflected by a 58% and 64% greater incremental area under the
Figure 1. Effects on HFru and HFat feeding on weight gain,
adiposity and liver triglyceride. Male C57BL/6J mice (13–16 weeks
old) were fed a high-fructose (HFru) or a high-fat (HFat) diet ad libitum
as compared to a standard laboratory chow diet (CH). The body weight
was similar among the three groups at the start of the feeding
intervention (23.660.3, 23.460.5 and 23.760.5 g). (A) Body weight gain
over the baseline. (B) Weight of epididymal fat depots. (C) Liver
triglyceride content. Liver samples were freeze-clamped for the
measurement of hepatic triglyceride content after 5–7 hour of fasting.
Data are mean 6 SE of 8–13 mice per group. ** p,0.01; { p,0.05, {{
p,0.01 vs HFru.
doi:10.1371/journal.pone.0030816.g001
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mice; Figure 2A). To assess the effect of the diets on hepatic insulin
signal transduction, we examined the phosphorylation of the key
signaling proteins, Akt and GSK-3b, in response to insulin
stimulation. As expected, insulin-stimulated Akt phosphorylation
was blunted in both HFru (57%, p,0.01) and HFat-fed (42%,
p,0.01) compared with CH-fed mice (Figure 2B). Consistent with
these changes, the insulin-stimulated phosphorylation of GSK-3b
was also reduced (53% in HFru and 52% in HFat mice, p,0.01;
Figure 2C). These results indicate decreased hepatic insulin
sensitivity in both HFru and HFat-fed mice.
HFru and HFat feeding exerted opposite effects on
hepatic de novo lipogenesis
As hepatic steatosis can result from an increase in either de novo
lipogenesis (DNL) or influx of fatty acids, we measured the rate of
incorporation of [
3H]-H2O into triglyceride to determine whether
DNL was altered by HFru or HFat feeding. As expected, HFru
feeding resulted in an increased rate of DNL (63%, p,0.01) while
HFat feeding decreased DNL (32%, p,0.05; Figure 3A). In
agreement with these metabolic changes, HFru-fed mice exhibited
dramatic increases in the protein expression of ACC (by 6.4-fold),
FAS (by 2.7-fold) and SCD-1 (by 8.0-fold) (p,0.01; Figure 3B, C
and D). In contrast, HFat feeding reduced the protein expression
of ACC (by 45%) and SCD-1 (by 78%) (both p,0.05), but not
FAS. DNL is believed to be under the regulation of two master
transcription factors: SREBP-1c and ChREBP [1,2,28,29,30]. We
found a significant increase of SREBP-1c protein expression in
both HFru- (2.3 fold) and HFat-feeding (2 fold) (p,0.01 vs Ch;
Figure 3E), whereas the protein expression of ChREBP remained
unaltered (Figure 3F). Interestingly, HFru feeding significantly
increased the mRNA expression of both SREBP-1c (3.3 fold,
p,0.01) and ChREBP (44%, p,0.05; Figure S1A and B), while
HFat feeding also resulted in a 50% induction of SREBP-1c
mRNA expression (p,0.01). These results further demonstrated
the effects of HFru and HFat feeding on different lipid metabolic
pathways.
HFru and HFat feeding did not alter mitochondrial
metabolism in the liver
Given the important role of the mitochondria in substrate
utilisation, we next sought to examine whether mitochondrial
functions were altered by HFru feeding. Measurement of
mitochondrial oxidation capacity from the liver homogenates
using palmitate and glutamate as substrates revealed no difference
compared to the CH group (Figure 4A and B). Consistent with
this, we also found no defects in the expression level of key proteins
in the respiratory chain (complex I–III and V; Figure 4C). Neither
the key regulators of mitochondrial biogenesis (PGC-1a), fatty acid
oxidation (CPT-1, COX-1), nor the marker for mitochondrial
numbers in cells (VDAC) [31] were altered by HFru or HFat
feeding (Figure 4C). However, the activity of citrate synthase, an
enzyme that catalyses the first step in the citric acid cycle, was
significantly enhanced by both HFru and HFat feeding (both
p,0.05 vs CH; Figure 4E). HFat feeding resulted in an increase
activity of b-HAD (p,0.05 vs CH), while the effect of HFru
feeding was not statistically significant (p.0.05 vs CH; Figure 4F).
These results indicate that mitochondrial function was up-
regulated in both HFat and HFru feeding, suggesting increased
rather than decreased oxidation of fatty acids.
Neither HFru nor HFat feeding was associated with
oxidative stress in the liver
As reactive oxygen species are important by-products of an
increased b-oxidation of long chain fatty acids which could cause
oxidative stress to the tissue, we measured NADPH oxidase
activity and glutathione (GSH) content for evidence of oxidative
stress. In contrast to the increased activity of b-HAD, HFat feeding
did not result in an increase activity of NAHPH oxidase (Figure 5A)
or a reduction in whole tissue GSH content (Figure 5B) which are
hallmarks of oxidative stress [32,33].
HFru and HFat feeding exerted different effects on JNK,
IKK activation and ER stress
Activation of JNK and IKK has been suggested to be associated
with hepatic steatosis and impaired insulin signal transduction
[15]. We found a 2 fold increase in p-JNK/t-JNK in HFat-fed
mice (p,0.01; Figure 6A), indicating the presence of cellular stress
in response to extrahepatic lipid oversupply. In HFru-fed mice,
however, the phosphorylation of JNK remained unaltered. The
relative phosphorylation of IKK a/b and the total levels of IkBa
in both HFru and HFat-fed mice were not significantly different
from CH-fed mice (Figure 6B & C).
Recent studies have highlighted ER stress as an important
mechanism integrating various pathways leading to insulin
resistance during obesity [15,16]. To investigate whether ER
stress was associated with the pathogenesis of hepatic steatosis, we
examined the activation of the unfolded protein response (UPR)
pathways for markers of ER stress. The protein level of ATF6 was
not affected by either HFru or HFat diet (Figure 7A). However,
HFru feeding markedly increased the phosphorylation of PERK
(2.2 fold), eIF-2a (2.6 fold) and IRE1 (2.1 fold; p,0.01; Figure 7B–
D). Consistent with the increased IRE1 phosphorylation, the
abundance of the spliced form of the X-box binding protein 1
(XBP1s) mRNA was also increased (Figure 7E). However, no
significant changes of these markers were detected in HFat-fed
Table 1. Basal metabolic parameters of HFru and HFat-fed
mice.
CH HFru HFat
Body mass (g)
Week 1 24.160.4 24.960.5 24.560.5
Week 8 27.860.6 28.760.6 28.060.8
Caloric intake (Kcal/kg.day)
Week 1 430675 3 9 616** 572623**
Week 8 443611 497624* 49864**
VO2 (ml/kg/h)
Week 1 3368627 3733635** 3968638**
Blood glucose (mM)
Week 1 6.260.2 6.260.3 6.660.3
Week 8 6.660.2 7.860.4* 8.260.2**
Plasma insulin (nmol/L)
Week 1 ND ND ND
Week 8 0.2260.02 0.2560.03 0.1960.02
Plasma triglyceride (mM)
Week 1 0.9960.02 1.1160.06 1.1160.06
Week 8 1.1560.13 0.7860.06 1.0360.07
ND, not determined. Data are means 6 SE of 10–15 mice per group.
*p,0.05,
**p,0.01 vs CH-fed mice.
doi:10.1371/journal.pone.0030816.t001
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two ER stress pathways were also observed on day 3 and week 8
(data not shown).
Discussion
The present study investigated the roles of mitochondrial
metabolism and ER stress in the development of hepatic steatosis
and insulin resistance induced by excessive DNL (HFru feeding)
compared to extrahepatic lipid oversupply (HFat feeding). Our
data showed that both conditions led to a rapid development of
hepatic steatosis and insulin resistance without any detectable
mitochondrial dysfunction. Compared with HFat diet, HFru
feeding resulted in greater hepatic steatosis throughout the period
of the study (8 weeks). Interestingly, DNL-induced steatosis and
insulin resistance co-existed with a marked activation of the
PERK/eIF2a and IRE1/XBP1 arms of the ER stress pathways
while lipid oversupply was associated with the activation of JNK
rather than ER stress at the early stage. In ob/ob mice, the relief of
ER stress by overexpressing the chaperone protein GRP78 has
been shown to reduce hepatic steatosis by inhibiting SREBP-1c
mediated lipogenesis [29]. In keeping with this report, our data
suggest that activation of ER stress pathways may play an
important role in DNL and subsequent changes in lipid hepatic
steatosis and insulin resistance during HFru feeding. Importantly,
our data clearly show a divergence in ER stress pathways between
intrahepatic DNL and extrahepatic lipid supply on the initiation of
hepatic steatosis and insulin resistance independent of obvious
mitochondrial defects. Such diverged ER stress response to DNL
and lipid oversupply has not been reported in previous studies
using genetically obese animals [13,15,16,18].
Fructose and fat are the major dietary factors leading to the
development of hepatic steatosis and insulin resistance in humans
[4,5,7]. Chronic feeding of diets high in either of them in animals
is known to cause hepatic steatosis, insulin resistance and obesity
resembling the metabolic syndrome in humans [7,8,34]. We first
Figure 2. Effects of HFru and HFat feeding on glucose tolerance and hepatic insulin signal transduction. The experiments were
performed after one week of high fructose (HFru, &), high fat (HFat, %) or chow (CH, N) feeding. (A) Glucose tolerance test (GTT) was performed with
an injection of glucose (3 g/kg, ip) after 5–7 hours of fasting. Data are mean 6 SE, 6–10 mice per group. iAUC, incremental area under the curve for
blood glucose level. Insulin signal transduction was assessed by immunoblotting of phosphorylated-Akt (Ser473) (B) and -GSK3b (Ser219) (C) in the
liver in response to a bolus of insulin stimulation (2 U/kg, ip). Each lane represents a single mouse. Densitometry data are mean 6 SE of 6 mice per
group. ** p,0.01.
doi:10.1371/journal.pone.0030816.g002
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and HFat feeding. The results showed both diets generated hepatic
steatosis within 3 days and this metabolic phenotype was sustained
beyond one week. We have noted that HFru- and HFat-feeding
resulted in different degrees of hepatic TG accumulation. This
may complicate the interpretation of our findings in the HFru
animals because the deleterious effects of hepatic lipid accumu-
lation are well documented [35]. Despite the similar TG levels in
the liver of the 3 day HFat-fed mice to 1–8 weeks of HFru-fed
mice, the HFat-fed mice did not exhibit the same ER stress
markers. These data indicate that the observed hepatic ER stress
induced by HFru feeding is unlikely to result from the greater TG
levels per se when compared with HFat feeding.
As expected, one week of HFru feeding substantially increased
hepatic DNL along with a dramatic up-regulation of lipogenic
enzymes ACC, FAS and SCD-1, mediated mainly by SREBP-1c
and as previously suggested [1,36]. Although ChREBP protein
levels were similar among the three groups, we did detect a 50%
increase in ChREBP mRNA with HFru feeding (p,0.05) as
previously reported [37]. Further studies are needed to clarify the
role of ChREBP in fructose-induced DNL as ChREBP protein
requires nuclear translocation to exert its function [38,39]. In
contrast, HFat feeding significantly down-regulated ACC and
SCD-1 and suppressed [
3H]-H2O incorporation into triglyceride,
confirming the inhibitory effect of dietary fat (long chain fatty
acids) on hepatic DNL and the involvement of ACC and SCD-1 as
Figure 3. Effects of HFru and HFat on hepatic DNL, lipogenic protein levels and protein expression of SREBP-1c and ChREBP. After
one week of HFru or HFat feeding, (A) hepatic DNL was measured by the incorporation of [
3H]-H2O into hepatic triglyceride (n=8/group). Protein
levels of lipogenic enzymes ACC (B), FAS (C) and SCD-1 (D) were determined by immunoblots. Each lane represents a single mouse. Densitometry
data are mean 6 SE of 6 mice per group. Protein expressions of the lipogenic transcription factors SREBP-1c (A) and ChREBP (B) were determined by
western blotting. Data are mean 6 SE relative to CH-fed mice of 6 mice per group. * p,0.05, ** p,0.01. { p,0.05 vs CH.
doi:10.1371/journal.pone.0030816.g003
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dependent on the proteolytic cleavages [36] and this process is
influenced by fatty acids [41], the suppressed DNL during the
HFat feeding may be due to the inhibitory effects of an increased
influx of fatty acids at the sites distal from SREBP-1c.
Mitochondrial dysfunction has been shown to be associated with
hepatic steatosis and insulin resistance in humans [9,42].
Decreased fatty acid oxidation along with impaired mitochondrial
function has been demonstrated in animal models with severe
NAFL such as diabetic ZDF rats [43] and OLETF obese rats [11],
and mice fed a high fructose corn syrup (HFCS-55) enriched diet
for 30 weeks [44]. We measured markers of mitochondrial content
and also substrate oxidative capacity in tissue homogenates, and
found no obvious mitochondrial defects following HFru or HFat
feeding. In fact, the activity of citrate synthase was enhanced by
both HFru and HFat feeding with an increased b-HAD activity
found in the HFat group. The lack of liver mitochondrial
dysfunction has been observed in HFat-fed mice in our previous
studies (4–5 wks of feeding) [23,45] and others [46]. These
findings together suggest that liver mitochondrial dysfunction is
likely to be a consequence of prolonged lipid toxicity effects [46]
which may exacerbate hepatic steatosis rather than a primary
contributor in the early stage.
Hepatic insulin resistance in both HFat and HFru-fed rodents
has been well characterized by the use of hyperinsulinemic-
euglycemic clamp coupled with glucose tracers [8,21,34]. Having
confirmed the development of hepatic insulin resistance (impaired
glucose tolerance and the blunted insulin-stimulated phosphory-
lation of Akt and GSK3b in the liver), we next investigated the
involvement of JNK and IKK as mediators of steatosis and insulin
resistance. JNK and IKK are the key stress-activated kinases to
disrupt insulin signal transduction by serine-phosphorylating
IRS1/2 leading to insulin resistance in HFat-fed mice [15].
Consistent with these reports, we detected an enrichment of
Figure 4. Effects of HFru and HFat feeding on mitochondrial oxidation, key protein expressions and enzymatic activities. After one
week of HFru or HFat feeding, the rates of hepatic oxidation of palmitate (A) and glutamate (B) were measured in liver homogenates using [1-
14C]-
palmitate or [1-
14C]-glutamate as substrates. Data are mean 6 SE from 6 mice per group. (C) Levels of key proteins for mitochondrial oxidation,
biogenesis and numbers were measured by immunoblots. Each lane represents a single mouse, 6 mice per group. The specific activity of citrate
synthase (D) and b-HAD (E), data are mean 6 SE from 6 to 8 mice per group. * p,0.05 vs CH.
doi:10.1371/journal.pone.0030816.g004
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and GSK3b phosphorylation in the HFat group. However, these
stress pathways were not activated in the HFru group, suggesting
that neither JNK nor IKK was involved in the development of
hepatic steatosis and insulin resistance induced by DNL. In
addition, JNK has also been shown to be the key mediator of ER
stress leading to insulin resistance during hepatic steatosis
[13,15,18]. However, we found no indication of JNK or IKK
Figure 5. Effects of HFru and HFat feeding on oxidative stress. After one week of HFru or HFat feeding, the activity of NADPH oxidase (A) and
intracellular GSH content (B) were quantified in liver homogenates, data are mean 6 SE of 6 to 8 mice per group. *** p,0.001.
doi:10.1371/journal.pone.0030816.g005
Figure 6. Effects of HFru and HFat on JNK and IKK activation. After one week of HFru or HFat feeding, liver homogenates were
immunoblotted for p-JNK/t-JNK (A), and p-IKKa/b/t-IKKa/b (B) and t-IKBa (C). Each lane represents a single mouse. Densitometry data are mean 6 SE
of 6 mice per group. ** p,0.01 vs CH fed mice.
doi:10.1371/journal.pone.0030816.g006
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mice in the absence of ER stress. These data indicate that neither
JNK nor IKK is required for the induction of hepatic insulin
resistance in response to an enhanced DNL [15].
Another factor that has been described as an important
mechanism in causing insulin resistance is oxidative stress
[47,48], particularly in the state of elevated fatty acid oxidation
[49,50,51,52,53]. However, the lack of changes in the oxidative
stress indicators in the liver (NADPH oxidase activity and GSH
content) suggests that the hepatic insulin resistance induced by
HFat and HFru in the present study is not attributable to oxidative
stress as a major factor. Given the rapid accumulation of
triglyceride in the liver in both HFru and HFat mice, the observed
hepatic insulin resistance is likely to result from associated
increases in lipotoxic metabolites such as diacylgerol glycerol
(DAG) or ceramide. Interestingly, HFru feeding has been shown to
Figure 7. Effects of HFru and HFat on ER stress markers in the liver. After one week of HFru or HFat feeding, animals were fasted for 5-
7 hours before tissue collection and liver homogenates were immunoblotted for markers of ER stress. (A) ATF6/b-actin (n=4/group), (B) p-PERK, (C)
p-eIF2a/t-eIF2a,( D) p-IRE1/t-IRE1, and (E) the post-transcriptional splicing of XBP1 transcript. Each lane represents a single mouse. Densitometry data
are mean 6 SE of 6 mice per group. ** p,0.01.
doi:10.1371/journal.pone.0030816.g007
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ceramide is known to dephosphorylate AKT [6], we postulate this
is a likely mechanism for the reduced hepatic pAKT in response to
insulin stimulation in HFru-fed mice. As for the HFat feeding,
several studies have shown significant increase of DAG in the liver
[56,57,58]. DAG can activate lipid-sensitive PKC isoforms such as
-h and -e [59] which phosphorylates the serine/threonine residues
of IRS to interrupt insulin-mediated phosphorylations at the
tyrosine sites required for the signal transductions [7]. Thus, while
both HFat and HFru diets are capable of causing hepatic steatosis,
the mechanisms of associated hepatic insulin resistance may not be
necessarily the same at the molecular level.
Recent studies have highlighted ER stress as an important
mechanism integrating various pathways leading to insulin
resistance during obesity [15,16]. Previous studies have shown
the involvement of the PERK/eIF2a and IRE1/XBP1 arms of the
ER stress signaling pathways in hepatic steatosis and insulin
resistance [15,16]. In agreement with this, these two arms of ER
stress signaling were significantly activated in response to HFru
feeding. However, we did not detect any significant changes in
ATF6, p-PERK, p-IRE1, p-eIF2a . , or XBP1 splicing, after one
week of HFat feeding when hepatic steatosis and insulin resistance
were clearly present.
As ER stress can be triggered by the overload of newly
synthesised unfolded proteins, the observed ER stress in this study
may well result from the marked increases in lipogenic enzymes,
given that high carbohydrate has been demonstrated to up-
regulate lipogenic enzymes via the actions of SREBP-1c and
ChREBP [36]. On the other hand, recent data have also indicated
that ER stress may be able to directly promote lipogenesis [15,17].
Of particular interest is the IRE1/XBP1 branch, which is found to
be activated during elevated DNL in the present study. XBP1 is a
nuclear transcriptional factor that can bind to the promoter
regions of ACC and SCD-1 to increase lipogenesis [17]. XBP1 can
also directly interact with the regulatory subunit of PI3K, p85a ..,i n
the insulin signaling pathway to facilitate its transcriptional activity
on genes involved in lipogenesis [60,61]. It is possible that XBP-1
may interact with SREBP-1c which serves as a crosstalk point
between ER stress and lipogenesis. However, further studies are
needed to dissect the causal relationship among ER stress signaling
pathways, lipogenesis and insulin resistance, as additional players
in ER stress might be involved [15].
In summary, the present study showed that the involvement of
ER stress pathways in the development of hepatic steatosis and
insulin resistance is induced only by dietary HFru but not by HFat
feeding, suggesting that ER stress is involved in DNL per se rather
than resulting from hepatic steatosis. Neither JNK nor IKK is
required for the ER stress-induced insulin resistance as previously
suggested in genetic models of obesity [13,15,16,18]. Our data also
indicated that mitochondrial dysfunction is unlikely to be a
primary cause of hepatic steatosis and insulin resistance induced
by HFru or HFat feeding. As insulin resistance is known to be
multifactorial, our studies in these two nutritional models provide
new insight into the potential role of different lipid metabolic
pathways linking to hepatic steatosis and insulin resistance.
Supporting Information
Figure S1 mRNA expression of SREBP-1c and ChREBP.
After one week of HFru or HFat feeding, mRNA expression of the
lipogenic transcription factors SREBP-1c (A) and ChREBP (B) was
determined by RT-PCR. Data are mean fold change 6 SE
relative to CH-fed mice of 6 mice per group. * p,0.05, ** p,0.01
vs CH.
(TIF)
Table S1 Specific primers for real time PCR.
(TIF)
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